← Zolgensma
What podcasts say about Zolgensma
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Zolgensma
1 statement · 1 positive
Zolgensma’s risk-benefit profile remains favorable in severe SMA.
“the risk benefit I would say is still favorable.”
Open the episode · Episode 202 - November 6, 2026Listen at 50:24
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.